64 related articles for article (PubMed ID: 15663893)
21. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
Zhang DM; He ZW; Liu XD; Li Y; Xie L; Wang GJ; Liu L
J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
[TBL] [Abstract][Full Text] [Related]
22. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
23. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
24. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
25. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
26. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
27. Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells.
Perloff MD; von Moltke LL; Fahey JM; Greenblatt DJ
J Pharm Pharmacol; 2007 Jul; 59(7):947-53. PubMed ID: 17637189
[TBL] [Abstract][Full Text] [Related]
28. Concentration dependency of modulatory effect of amlodipine on P-glycoprotein efflux activity of doxorubicin--a comparison with tamoxifen.
Darvari R; Boroujerdi M
J Pharm Pharmacol; 2004 Aug; 56(8):985-91. PubMed ID: 15285842
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
Yang ZH; Liu XD
Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
[TBL] [Abstract][Full Text] [Related]
30. P-glycoprotein restricted transport of nimodipine across blood-brain barrier.
Zhang L; Liu XD; Xie L; Wang GJ
Acta Pharmacol Sin; 2003 Sep; 24(9):903-6. PubMed ID: 12956939
[TBL] [Abstract][Full Text] [Related]
31. P glycoprotein regulated transport of glutamate at blood brain barrier.
Liu XD; Liu GQ
Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
[TBL] [Abstract][Full Text] [Related]
32. Platelet activating factor induces blood brain barrier permeability alteration in vitro.
Fang W; Geng X; Deng Y; Li Y; Shang E; Cen J; Lv P
J Neuroimmunol; 2011 Jan; 230(1-2):42-7. PubMed ID: 20870297
[TBL] [Abstract][Full Text] [Related]
33. Amlodipine treatment prevents angiotensin II-induced human umbilical vein endothelial cell apoptosis.
Bian YF; Yang HY; Yang ZM; Gao F; Zhang NN; Xiao CS
Arch Med Res; 2011 Jan; 42(1):22-7. PubMed ID: 21376258
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
[TBL] [Abstract][Full Text] [Related]
35. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
36. Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells.
Chan GN; Hoque MT; Cummins CL; Bendayan R
J Neurochem; 2011 Jul; 118(2):163-75. PubMed ID: 21517853
[TBL] [Abstract][Full Text] [Related]
37. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; Li M; He L
Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of P-glycoprotein mediated in vitro loperamide biliary excretion with sandwich-cultured rat hepatocytes model].
Shen GL; Zhuang XM; Yuan M; Sun HX; Li H
Yao Xue Xue Bao; 2012 Apr; 47(4):459-65. PubMed ID: 22799027
[TBL] [Abstract][Full Text] [Related]
39. Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells.
Pilorget A; Demeule M; Barakat S; Marvaldi J; Luis J; Béliveau R
J Neurochem; 2007 Mar; 100(5):1203-10. PubMed ID: 17316399
[TBL] [Abstract][Full Text] [Related]
40. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
